Evogene (EVGN) Tops Q2 EPS by 3c

Evogene (NASDAQ: EVGN) reported Q2 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $135 thousand versus the consensus estimate of $300 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Six Flags names Mark Pauls as chief operating officer
• MotorK names Roy Toren to board as Helen Protopapas resigns